Establishment of spinocerebellar ataxia type 34 model mice accompanied by early glial activation and degeneration of cerebellar neurons

Abstract

Spinocerebellar ataxia type 34 (SCA34) is an autosomal dominant neurodegenerative disease primarily characterized by progressive cerebellar atrophy and ataxia, frequently accompanied by cognitive dysfunction and erythrokeratodermia variabilis. In 2014, missense mutations in the gene encoding elongation of very long chain fatty acids protein 4 (ELOVL4) were identified as the causative gene for SCA34. ELOVL4, which is involved in the synthesis of very long chain fatty acids, is highly expressed in the cerebellum compared to other brain regions, with predominant expression in neurons. We attempted to establish a mouse model of SCA34 by expressing mutant ELOVL4 in cerebellar neurons using adeno-associated virus (AAV) vectors and to elucidate the underlying pathogenic mechanisms. Expression of W246G mutant ELOVL4 successfully induced progressive motor dysfunction beginning at two weeks post-AAV vector injection. Immunohistochemical analyses revealed that the degeneration of cerebellar Purkinje cells and neurons in the deep cerebellar nuclei (DCN) paralleled the observed motor decline. Importantly, microglial activation was detected in the molecular layer of the cerebellar cortices and the DCN prior to the onset of both neurodegeneration and motor dysfunction. Furthermore, after the onset of motor symptoms, the SCA34 model mice exhibited decreased synaptic inputs from climbing fibers to Purkinje cells, as well as reduced inputs from Purkinje cells to DCN neurons. These findings suggest that early microglial activation and the resulting synaptic disturbance are critical preceding events that lead to the progressive cerebellar neurodegeneration and motor dysfunction observed in this SCA34 mouse model.